Cel-Sci
CVM
#9766
Rank
ยฃ38.7 M
Marketcap
ยฃ4.84
Share price
2.54%
Change (1 day)
-63.23%
Change (1 year)

Cel-Sci (CVM) - Cash on Hand

Cash on Hand as of June 2025 : ยฃ1.34 Million

According to Cel-Sci 's latest financial reports the company has ยฃ1.34 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cel-Sci - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30ยฃ3.54 M4.22%
2023-09-30ยฃ3.39 M-83.32%
2022-09-30ยฃ20.37 M-34.98%
2021-09-30ยฃ31.33 M161.02%
2020-09-30ยฃ12 M74.73%
2019-09-30ยฃ6.87 M-13.1%
2018-09-30ยฃ7.9 M347.05%
2017-09-30ยฃ1.76 M-21.43%
2016-09-30ยฃ2.25 M-40.55%
2015-09-30ยฃ3.78 M-27.89%
2014-09-30ยฃ5.25 M20325.75%
2013-09-30ยฃ0.02 M-98.95%
2012-09-30ยฃ2.44 M-10.41%
2011-09-30ยฃ2.72 M-83.86%
2010-09-30ยฃ16.9 M-19.92%
2009-09-30ยฃ21.1 M4000%
2008-09-30ยฃ0.51 M-90.43%
2007-09-30ยฃ5.37 M24.6%
2006-09-30ยฃ4.31 M288.33%
2005-09-30ยฃ1.11 M-53.11%
2004-09-30ยฃ2.36 M125.28%
2003-09-30ยฃ1.05 M-21.07%
2002-09-30ยฃ1.33 M-17.48%
2001-09-30ยฃ1.61 M-77.78%
2000-09-30ยฃ7.26 M102.79%
1999-09-30ยฃ3.58 M-51.28%
1998-09-30ยฃ7.35 M238.69%
1997-09-30ยฃ2.17 M-2.88%
1996-09-30ยฃ2.23 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Curis
CRIS
ยฃ6.79 M 404.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ0.15 B 11,773.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ7.08 B 526,711.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
ยฃ0.35 B 26,173.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.65 B 122,776.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
ยฃ13.93 B 1,035,229.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.18 B 13,593.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
ยฃ2.28 M 69.95%๐Ÿ‡บ๐Ÿ‡ธ USA